Immunomodulatory effects of fosfomycin in experimental human endotoxemia

Antimicrob Agents Chemother. 2007 May;51(5):1879-81. doi: 10.1128/AAC.00914-06. Epub 2007 Mar 12.

Abstract

To evaluate the effect of fosfomycin on proinflammatory cytokines, a bolus of 2 ng of bacterial lipopolysaccharide/kg of body weight was injected intravenously into healthy volunteers. After 2 h, subjects received 8 g of fosfomycin or placebo in a randomized crossover study design. The resulting concentrations of tumor necrosis factor alpha, interleukin-1beta (IL-1beta), and IL-6 expressed as protein and mRNA levels were almost identical with and without fosfomycin.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Adolescent
  • Adult
  • Anti-Bacterial Agents / pharmacology*
  • Cytokines / blood*
  • Endotoxemia / immunology*
  • Fosfomycin / pharmacology*
  • Humans
  • Interleukin-1beta / blood
  • Interleukin-6 / blood
  • Lipopolysaccharides / toxicity
  • Male
  • Prospective Studies
  • Tumor Necrosis Factor-alpha / blood

Substances

  • Anti-Bacterial Agents
  • Cytokines
  • Interleukin-1beta
  • Interleukin-6
  • Lipopolysaccharides
  • Tumor Necrosis Factor-alpha
  • Fosfomycin